Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) is projected to release its Q2 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $242.6740 million for the quarter. Investors can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:00 PM ET.
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The business services provider reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. Cross Country Healthcare had a negative net margin of 9.84% and a negative return on equity of 0.74%. The company had revenue of $241.06 million during the quarter, compared to analyst estimates of $237.06 million. On average, analysts expect Cross Country Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Cross Country Healthcare Stock Performance
NASDAQ CCRN remained flat at $13.25 on Wednesday. Cross Country Healthcare has a 12 month low of $7.43 and a 12 month high of $14.99. The stock has a market capitalization of $428.05 million, a P/E ratio of -4.34, a P/E/G ratio of 14.32 and a beta of 0.45. The stock’s fifty day moving average price is $13.18 and its 200-day moving average price is $10.87.
Institutional Investors Weigh In On Cross Country Healthcare
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on CCRN. Barrington Research reiterated a “market perform” rating and issued a $13.25 price objective on shares of Cross Country Healthcare in a research report on Monday, June 8th. Wedbush cut Cross Country Healthcare from an “outperform” rating to a “hold” rating and reduced their target price for the stock from $15.00 to $13.25 in a research report on Thursday, May 7th. Benchmark cut Cross Country Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, May 8th. Citigroup lowered Cross Country Healthcare from a “market outperform” rating to a “market perform” rating in a research note on Thursday, May 7th. Finally, Weiss Ratings raised Cross Country Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 16th. Nine analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Cross Country Healthcare presently has a consensus rating of “Reduce” and an average target price of $12.05.
View Our Latest Stock Report on Cross Country Healthcare
About Cross Country Healthcare
Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.
The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.
See Also
- Five stocks we like better than Cross Country Healthcare
- Carrier Earnings Could Send the Stock to a New All-Time High
- 3 Unique AI Software Plays With Strong Analyst Support
- Amazon’s Satellite Push Raises the Stakes for SpaceX and AST SpaceMobile
- NVIDIA’s OpenAI Backstop Puts AI Financing Risk in Focus
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
